Strong Commercial Execution and Pipeline Opportunities Propel Corcept Therapeutics (CORT)
BUFFALO Funds, an actively managed mutual fund advised by Kornitzer Capital Management, released its second-quarter 2026 investor letter for “Buffalo Mid Cap Discovery Fund”.







